These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

621 related items for PubMed ID: 23482412

  • 1. DNA and histone methylation in gastric carcinogenesis.
    Calcagno DQ, Gigek CO, Chen ES, Burbano RR, Smith Mde A.
    World J Gastroenterol; 2013 Feb 28; 19(8):1182-92. PubMed ID: 23482412
    [Abstract] [Full Text] [Related]

  • 2. Cancer type-specific epigenetic changes: gastric cancer.
    Calcagno DQ, de Arruda Cardoso Smith M, Burbano RR.
    Methods Mol Biol; 2015 Feb 28; 1238():79-101. PubMed ID: 25421656
    [Abstract] [Full Text] [Related]

  • 3. Gene methylation in gastric cancer.
    Qu Y, Dang S, Hou P.
    Clin Chim Acta; 2013 Sep 23; 424():53-65. PubMed ID: 23669186
    [Abstract] [Full Text] [Related]

  • 4. Deciphering the underlying genetic and epigenetic events leading to gastric carcinogenesis.
    Vogiatzi P, Vindigni C, Roviello F, Renieri A, Giordano A.
    J Cell Physiol; 2007 May 23; 211(2):287-95. PubMed ID: 17238139
    [Abstract] [Full Text] [Related]

  • 5. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
    Sigalotti L, Fratta E, Coral S, Cortini E, Covre A, Nicolay HJ, Anzalone L, Pezzani L, Di Giacomo AM, Fonsatti E, Colizzi F, Altomonte M, Calabrò L, Maio M.
    J Cell Physiol; 2007 Aug 23; 212(2):330-44. PubMed ID: 17458893
    [Abstract] [Full Text] [Related]

  • 6. DNA methylation and histone modifications in patients with cancer: potential prognostic and therapeutic targets.
    Herranz M, Esteller M.
    Methods Mol Biol; 2007 Aug 23; 361():25-62. PubMed ID: 17172706
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of gastric carcinogenesis by the hormone gastrin is mediated by suppression of TFF1 epigenetic silencing.
    Tomita H, Takaishi S, Menheniott TR, Yang X, Shibata W, Jin G, Betz KS, Kawakami K, Minamoto T, Tomasetto C, Rio MC, Lerkowit N, Varro A, Giraud AS, Wang TC.
    Gastroenterology; 2011 Mar 23; 140(3):879-91. PubMed ID: 21111741
    [Abstract] [Full Text] [Related]

  • 8. Change in gene expression profiles of secreted frizzled-related proteins (SFRPs) by sodium butyrate in gastric cancers: induction of promoter demethylation and histone modification causing inhibition of Wnt signaling.
    Shin H, Kim JH, Lee YS, Lee YC.
    Int J Oncol; 2012 May 23; 40(5):1533-42. PubMed ID: 22246241
    [Abstract] [Full Text] [Related]

  • 9. Epigenetic modifications in gastric cancer: Focus on DNA methylation.
    Ebrahimi V, Soleimanian A, Ebrahimi T, Azargun R, Yazdani P, Eyvazi S, Tarhriz V.
    Gene; 2020 Jun 05; 742():144577. PubMed ID: 32171825
    [Abstract] [Full Text] [Related]

  • 10. Epigenetics in cancer: targeting chromatin modifications.
    Ellis L, Atadja PW, Johnstone RW.
    Mol Cancer Ther; 2009 Jun 05; 8(6):1409-20. PubMed ID: 19509247
    [Abstract] [Full Text] [Related]

  • 11. Targeting Chromatin Remodeling for Cancer Therapy.
    Kaur J, Daoud A, Eblen ST.
    Curr Mol Pharmacol; 2019 Jun 05; 12(3):215-229. PubMed ID: 30767757
    [Abstract] [Full Text] [Related]

  • 12. Methylation modification in gastric cancer and approaches to targeted epigenetic therapy (Review).
    Zeng XQ, Wang J, Chen SY.
    Int J Oncol; 2017 Jun 05; 50(6):1921-1933. PubMed ID: 28498404
    [Abstract] [Full Text] [Related]

  • 13. How to stomach an epigenetic insult: the gastric cancer epigenome.
    Padmanabhan N, Ushijima T, Tan P.
    Nat Rev Gastroenterol Hepatol; 2017 Aug 05; 14(8):467-478. PubMed ID: 28513632
    [Abstract] [Full Text] [Related]

  • 14. Epigenetics in prostate cancer: biologic and clinical relevance.
    Jerónimo C, Bastian PJ, Bjartell A, Carbone GM, Catto JW, Clark SJ, Henrique R, Nelson WG, Shariat SF.
    Eur Urol; 2011 Oct 05; 60(4):753-66. PubMed ID: 21719191
    [Abstract] [Full Text] [Related]

  • 15. Epigenetic interplays between DNA demethylation and histone methylation for protecting oncogenesis.
    Furuya K, Ikura M, Ikura T.
    J Biochem; 2019 Apr 01; 165(4):297-299. PubMed ID: 30605533
    [Abstract] [Full Text] [Related]

  • 16. Aberrant epigenetic regulation: a central contributor to lung carcinogenesis and a new therapeutic target.
    Juergens RA, Rudin CM.
    Am Soc Clin Oncol Educ Book; 2013 Apr 01. PubMed ID: 23714528
    [Abstract] [Full Text] [Related]

  • 17. Epigenetic Targets and their Inhibitors in Cancer Therapy.
    Zhao L, Duan YT, Lu P, Zhang ZJ, Zheng XK, Wang JL, Feng WS.
    Curr Top Med Chem; 2018 Apr 01; 18(28):2395-2419. PubMed ID: 30582481
    [Abstract] [Full Text] [Related]

  • 18. Effect of non-enzymatic glycosylation in the epigenetics of cancer.
    Rehman S, Aatif M, Rafi Z, Khan MY, Shahab U, Ahmad S, Farhan M.
    Semin Cancer Biol; 2022 Aug 01; 83():543-555. PubMed ID: 33276090
    [Abstract] [Full Text] [Related]

  • 19. Epigenetic mechanisms in gastric cancer.
    Gigek CO, Chen ES, Calcagno DQ, Wisnieski F, Burbano RR, Smith MA.
    Epigenomics; 2012 Jun 01; 4(3):279-94. PubMed ID: 22690664
    [Abstract] [Full Text] [Related]

  • 20. Pathogenetic mechanisms in gastric cancer.
    Shi J, Qu YP, Hou P.
    World J Gastroenterol; 2014 Oct 14; 20(38):13804-19. PubMed ID: 25320518
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.